Latest debt-to-equity ratio
Contineum Therapeutics Debt-to-equity ratio
Direct answer
Contineum Therapeutics's debt-to-equity ratio is 2.74%.
The verified market snapshot reports 2.74%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Contineum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.74%
Explore related company data
View Contineum Therapeutics's market capitalizationView Contineum Therapeutics's price-to-book ratioView Contineum Therapeutics's return on equityView Contineum Therapeutics's dividend yieldView Contineum Therapeutics's 52-week price rangeView Contineum Therapeutics's profit marginView all Contineum Therapeutics key metricsReturn to Contineum Therapeutics profile